The global synthetic leather market size is expected to reach USD 52.96 billion by 2027, according to a new study by Grand View Research, Inc. It is projected to expand at a strong CAGR of 7.8%, in terms of revenue during the forecast years. Increasing scope of application for the product in footwear has been a major factor driving the growth. Growing importance and awareness about animal rights along with stringent laws regarding the usage of real leather is anticipated to further fuel the product demand.
Key suggestions from the report:
- PU leather emerged as the largest product segment in 2019 and is estimated to generate revenue over USD 32.9 billion by 2027
- Asia Pacific (APAC) is projected to witness the fastest growth over the estimated period owing to rapid economic growth across countries, such as India, China, Japan, and Korea
- Rapid development of construction and automotive manufacturing industries in APAC is also fueling the product demand in the regional market
- Countries, such as South Korea, Taiwan, China, and India, are emerging as leading producers of synthetic leather in the global market as a result of available of relatively cheaper raw materials
- Key companies in the global synthetic leather market include Nan Ya Plastics Corporation, Mayur Uniquoters Limited, Alfatex Italia SRL, and Kuraray Co. Ltd.
Read 109 page research report with ToC on “Synthetic Leather Market Size, Share & Trends Analysis Report By Product (Bio-based, PVC, PU), By Application (Clothing, Furnishing, Automotive, Bags & Wallets, Footwear), By Region, And Segment Forecasts, 2020 – 2027” at: https://www.grandviewresearch.com/industry-analysis/synthetic-leather-market
Synthetic leather materials have superior properties, such as high gloss finish, durability, strength, UV resistance, and easy maintenance. Moreover, products made from faux leather are cheaper and thus, continue to attract consumers, especially from middle- and high-income level groups. However, in countries, such as Japan, the product is facing competition from Fumikodata, which is a replica of real leather and is a cruelty-free material. Polyurethane (PU) was the largest product category in 2017 and is expected to register the fastest CAGR over the forecast period.
PVC is anticipated to witness sluggish growth on account of its properties, such as sticky finish and lesser durability. Footwear application segment is expected to observe a considerable growth over the forecast period. Cheaper costs and fluctuating climatic conditions in several regions creates needs for different types of footwear. Rising disposable income levels in emerging regions are also fueling the demand for synthetic leather in the footwear segment. Rising use of athletic shoes in everyday life is further augmenting the product demand.
Grand View Research has segmented the global synthetic leather market based on product, application, and region:
- Synthetic Leather Product Outlook (Volume, Million Meter; Revenue, USD Million, 2016 – 2027)
- Synthetic Leather Application Outlook (Volume, Million Meter; Revenue, USD Million, 2016 – 2027)
- Bags & Wallets
- Synthetic Leather Regional Outlook (Volume, Million Meter; Revenue, USD Million, 2016 – 2027)
- North America
- Asia Pacific
- South Korea
- Central & South America
- Middle East & Africa
- North America
Find more research reports on Plastics, Polymers & Resins Industry, by Grand View Research:
- Polypropylene Compounds Market – The global polypropylene compounds market size was estimated at USD 15.78 billion in 2017. It is anticipated to register a CAGR of 7.6% over the forecast period.
- Silicone Solutions for Leather & Textiles Market – The global silicone solutions for leather & textiles market size was estimated at USD 555.2 million in 2017. Rising product innovation in terms of new apparels and accessories in fashion industry.
- Healthcare Personal Protective Equipment Market – Global healthcare personal protective equipment market is projected to grow at a significant rate over the forecast period owing to the rising demand for protective clothing, respiratory and hand protective gears in the medical industry to ensure employees safety and wellbeing.
SOURCE Grand View Research, Inc.
OMNIQ’s CEO Interviewed on “CEO Roadshow”
SALT LAKE CITY, April 01, 2020 (GLOBE NEWSWIRE) — OMNIQ Corp. (OMQS) (“OMNIQ” or “the Company”), a provider of Supply Chain and Artificial Intelligence (AI)-based solutions, today announced that its CEO, Shai Lustgarten, recently conducted an interview with Mike Elliott of CEO Roadshow.
The interview may be viewed in its entirety via: CEORoadshowhttp://ceoroadshow.com/ceoroadshow-interview-with-shai-lustgarten-president-ceo-of-omniq-corp-omqs/Interview Highlights:OMNIQ provides unique and scalable AI-Machine Vision technology solutions to the Public Safety, Supply Chain and Automated parking industriesCompany customer base comprised of Fortune 500 leading companies, governments, municipalities, schools and colleges, cultural and religious centers and others.Company participates in rapidly growing, multi-billion dollar market verticalsOMNIQ holds 8 patents and has developed algorithms applicable to:
– Vehicle comprehensive license plate, color and make recognition for use in homeland security, public safety and automated parking
– AI-based Machine Vision solutions for supply chain & logistics promoting efficiencies from warehouse/yard management through point of sale
– Comprehensive parking management solution enabling ticketless parking, automation and revenue control currently installed at more than 30 major airports in the U.S.Company in a unique position offering state-of-the-art, high margin technology solutionsAbout OMNIQ, Corp.
OMNIQ Corp. (OMQS) provides computerized and machine vision image processing solutions that use patented and proprietary AI technology to deliver data collection, real time surveillance and monitoring for supply chain management, homeland security, public safety, traffic & parking management and access control applications. The technology and services provided by the Company help clients move people, assets and data safely and securely through airports, warehouses, schools, national borders, and many other applications and environments.
OMNIQ’s customers include government agencies and leading Fortune 500 companies from several sectors, including manufacturing, retail, distribution, food and beverage, transportation and logistics, healthcare, and oil, gas, and chemicals. Since 2014, annual revenues have grown to more than $50 million from clients in the USA and abroad.
The Company currently addresses several billion-dollar markets, including the Global Safe City market, forecast to grow to $29 billion by 2022, and the Ticketless Safe Parking market, forecast to grow to $5.2 billion by 2023. “Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995. Statements in this press release relating to plans, strategies, economic performance and trends, projections of results of specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. This release contains “forward-looking statements” that include information relating to future events and future financial and operating performance. The words “anticipate”, “may,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management’s good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause these differences include, but are not limited to: fluctuations in demand for the Company’s products particularly during the current health crisis , the introduction of new products, the Company’s ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company’s liquidity and financial strength to support its growth, the Company’s ability to manage credit and debt structures from vendors, debt holders and secured lenders, the Company’s ability to successfully integrate its acquisitions, and other information that may be detailed from time-to-time in OMNIQ Corp.’s filings with the United States Securities and Exchange Commission. Examples of such forward looking statements in this release include, among others, statements regarding revenue growth, driving sales, operational and financial initiatives, cost reduction and profitability, and simplification of operations. For a more detailed description of the risk factors and uncertainties affecting OMNIQ Corp., please refer to the Company’s recent Securities and Exchange Commission filings, which are available at http://www.sec.gov. OMNIQ Corp. undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless otherwise required by law.Investor Contact:
John Nesbett/Jen Belodeau
IMS Investor Relations
Enterprise Connect Announces Winners for the Best of Enterprise Connect Industry Awards
SAN FRANCISCO, April 01, 2020 (GLOBE NEWSWIRE) — Enterprise Connect, the leading conference and exhibition for enterprise communications and collaboration, is pleased to announce the winners for The Best of Enterprise Connect awards program. Best of Enterprise Connect recognizes excellence and innovation in the enterprise communications and collaboration industry.
“We’d like to extend a congratulations to all of this year’s Best of Enterprise Connect winners and participants,” said Eric Krapf, Enterprise Connect General Manager and Program Co-Chair. “These companies represent the most innovative technologies that are making a significant impact on the enterprise communications and collaboration industry.”Recipients of The Best of Enterprise Connect Awards include:OVERALL Best of Enterprise Connect (Winner)JourneyJourney Identity Platform, which aims to make it easy for enterprises to establish trusted interactions with their customers that simultaneously solve for security, customer experience and privacy using an encrypted network and a platform of best-in-class identity solutions that can be dynamically applied using the enterprise’s existing mobile app.OVERALL Best of Enterprise Connect (Finalists)Genesys Predictive Engagement, now working within Genesys Cloud, new capabilities enable businesses to anticipate individual customer needs, building on every interaction across multiple channels and events to improve and personalize future engagements.Glia Conversational Compliance AI Framework, part of Glia’s digital-first customer service platform, provides the framework to provision, measure and manage AI-driven virtual assistants to converse with customers and operator assistants to guide agents.Mio’s new intercompany federation for Microsoft Teams, Slack and Cisco WebEx Teams enables users to chat seamlessly with external business contacts who use a different messaging app.Omilia Natural Language Solutions — Omilia Cloud Platform miniApps, zero-touch natural language microservices that handle a single dialog task; instantly deployable to any call center provider and seamlessly adapted to any CCaaS service creation environmentPexip, Adaptive Composition, an AI-powered technology with real-time face detection, auto-framing, and optimized use of screen real estate; works with any camera-enabled deviceBest Innovation for Meeting Rooms (Three-way tie)AvayaAvaya Spaces, a simple cloud solution that integrates friction-free web meetings and team collaboration into one app.Kramer ElectronicsVIA GO², which gives iOS, Android, Chromebook, PC and Mac users instant wireless connectivity with advanced presentation technology, featuring content streaming for 4K mirrored images and video playback.RingCentralFor a new product that will be announced at Enterprise Connect.Best Innovation in Customer ExperienceJourneyJourney Identity Platform, which aims to make it easy for enterprises to establish trusted interactions with their customers that simultaneously solve for security, customer experience and privacy using an encrypted network and a platform of best-in-class identity solutions that can be dynamically applied using the enterprise’s existing mobile app.Best Application of Artificial Intelligence (Three-way tie)GenesysGenesys Predictive Engagement, now working within Genesys Cloud, new capabilities enable businesses to anticipate individual customer needs, building on every interaction across multiple channels and events to improve and personalize future engagements.PexipAdaptive Composition, an AI-powered technology with real-time face detection, auto-framing and optimized use of screen real estate; works with any camera-enabled device.Theta LakeCompliant Collaboration Archive, new module within Theta Lake’s Compliance Suite for record keeping, archiving and eDiscovery requirements for video, audio and collaboration chat, with on-demand compliance risk analysis using AI and ML across leading UCaaS platforms (RingCentral, WebEx, Microsoft Teams, Zoom, LogMeIn, Red Box).Best Innovation for Advancing Employee/End User EngagementEmbrava (Winner)Embrava Desk Sign, a smart sensor IoT device designed for Hot Desking, Office Hoteling and Activity-Based Working.Mio (Runner-up)Mio’s new intercompany federation for Microsoft Teams, Slack and WebEx Teams, enables users to seamlessly chat with their external business contacts who use a different messaging app.Best of Enterprise Connect judges for 2020 included: Jon Arnold, principal, J Arnold & Associates; Brent Kelly, president & principal analyst, KelCor; Steve Leaden, president, Leaden Associates and Sheila McGee-Smith, founder & principal analyst, McGee-Smith Analytics.Enterprise Connect 2020 will take place August 3rd– 6th at the Moscone Center in San Francisco. For more information on #E20 and to register for the event, go to www.enterpriseconnect.com/sanfrancisco.About Enterprise Connect
For 30 years, Enterprise Connect has been the leading conference and exhibition for enterprise Unified Communications and Collaboration in North America. Enterprise Connect brings corporate IT decision makers together with the industry’s vendors, analysts and consultants to focus on the issues central to enterprise networks and communications. Enterprise Connect owns and produces No Jitter, (nojitter.com), providing daily blogging and analysis of enterprise communications, and it also serves the community with a weekly email newsletter, research surveys and a Webinar Series. For more information, visit enterpriseconnect.com/sanfrancisco. Enterprise Connect is brought to you by Informa Tech.About Informa Tech
Informa Tech is a market leading provider of integrated research, media, training and events to the global Technology community. We’re an international business of more than 600 colleagues, operating in more than 20 markets. Our aim is to inspire the Technology community to design, build and run a better digital world through research, media, training and event brands that inform, educate and connect. Over 7,000 professionals subscribe to our research, with 225,000 delegates attending our events and over 18,000 students participating in our training programs each year, and nearly 4 million people visiting our digital communities each month. Learn more about Informa Tech.Media Contact:
Cancer Biomarker Sales to Reach US$ 27 Bn by 2025; Government Funding Pivotal in Accelerating Market Growth, Says a New Fact.MR Report
Dubai, UAE, April 01, 2020 (GLOBE NEWSWIRE) — The global cancer biomarker market will reach a valuation of US$ 27 Bn by the end of 2025, as projected by a new Fact.MR report. The growth is primarily driven by the increasing prevalence of cancer and the subsequent investments in research and development activities. Factors further complementing the growth are favorable government funding initiatives on cancer diagnostics.Cancer Biomarker Market: Key FindingsCirculating Tumor Test (CTT) and Prostate Specific Antigen (PSA) test collectively account for more than half of overall market value.On the back of high cigarette smoking, lung cancer is expected to be the most common type of cancer, thereby accounting for a quarter total market share in testing.North America is set to account for a large portion of the overall global revenue, on the back of heavy budget allocation by the government for cancer research and training.Asia-Pacific will witness tremendous growth owing to the increasing affordability of cancer treatments in emerging economies.Request Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=4587Cancer Biomarker Market: Key Driving FactorsGovernments in developed and emerging economies are financing clinical trials, thus enabling companies to develop effective diagnostics and treatments for cancer diseases, thus giving a significant boost to the global cancer biomarker market.Invigorated by technological advancements, numerous companies in the diagnostic imaging market are developing advanced, efficient, and economical equipment, and hence, are gaining traction among end-users.Explore the complete cancer biomarkers market report with detailed market segmentation, 64 illustrative figures, and 18 data tables at –
https://www.factmr.com/report/4587/cancer-biomarkers-marketCancer Biomarker Market: Key RestraintMajor factors possessing a challenge to the rapid growth of the market are reluctance among end-users to adopt new technologies and the high cost of biomarker techniques.Competition LandscapeSome of the key players in the global cancer biomarker market are F. Hoffmann-La Roche Ltd., Abbott Technologies & Merck & Co., Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Illumina, Inc., bioMérieux SA, Hologic, Inc., Genomic Health, Inc., and QIAGEN, among others. The market players are adopting Artificial Intelligence (to) to develop their offerings and to decode the cancer pathology.About the ReportThis 170-page study offers a detailed market forecast on the cancer biomarker market. The key categories covered in the report include Market statistics have been presented on the basis of Test Type (PSA tests, CTC tests, AFP tests, CA tests, HER2 tests, BRCA tests, ALK tests, CEA tests, EFGR mutation tests, KRAS mutation tests, and Others) and Disease Indication (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, etc.) across five major regions.Explore Fact.MR’s lucid coverage of the healthcare landscapeAutomated External Defibrillators Market– The automated external defibrillators market study analyses the key trends, innovations, regulatory policies, and key strategies adopted by leading players in this evolving landscape.Atopic Dermatitis Market– The study analyses the atopic dermatitis market and offers growth opportunities in USD million across 30+ countries in six regions.Rare Neurological Disease Treatment Market– With strong growth through 2028, the rare neurological disease market is witnessing substantial growth in a market.About Fact.MRExpert analysis, actionable insights, and strategic recommendations of the highly seasoned research team at Fact.MR helps clients from across the globe with their unique business intelligence needs. With a repertoire of over a thousand reports and 1 million-plus data points, the team has analyzed the Healthcare sector across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services. Fact.MR’s latest healthcare market research reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition.Contact:Fact.MR11140 Rockville PikeSuite 400Rockville, MD 20852United StatesEmail: email@example.comWeb: https://www.factmr.com/PR- https://www.factmr.com/media-release/1360/global-cancer-biomarkers-market
Latest News9 months ago
Bleckwen Raises $10m and Appoints David Christie as CEO
Artificial Intelligence11 months ago
Kneron Debuts Edge AI Chip, Bringing AI to Devices Everywhere
Artificial Intelligence12 months ago
Chartis Research Names FICO a Category Leader in AI for Financial Services
Artificial Intelligence10 months ago
LogRhythm Scores the Singapore Business Review Technology Excellence Award 2019 for Cyber Security – Computer Software
Artificial Intelligence12 months ago
CredoLab extends smartphone-based scoring to insurers
Artificial Intelligence12 months ago
Tuya Exhibiting Products from its Global Clients that are “Powered by Tuya”
Artificial Intelligence10 months ago
Chengdu Tianfu Software Park Reflects the Vitality of IP Innovation
Artificial Intelligence6 months ago
Mogo announces a digital lending pilot with goeasy Ltd.